Cell therapy for joint diseases
Cell therapy for diseases and injuries of the musculoskeletal system is based on the use of biomedical cell products (BMCP). As a cellular component, we use autologous (i.e., our own) mesenchymal stem cells (MSC) isolated from the patient’s adipose tissue and cultured in laboratory conditions to the required amount. These stem cells, possessing a high differentiation and proliferative potential, are capable of chondrogenesis and are natural candidates for participation in the restoration of damaged joint cartilage tissue.
The department’s specialists have worked out the algorithm for this innovative treatment technology – from the initial examination of the patient and the collection of biomaterial (adipose tissue) to performing intra-articular cell transplantation under ultrasound guidance. The course of cell therapy for osteoarthritis of large joints (hip, knee, shoulder) includes several transplants with an interval of 10-14 days.
The clinical result of cell therapy for osteoarthritis is the relief of pain syndrome (usually within 2 to 3 weeks), improvement of the functional capabilities of the joint, and slowing of the progression of arthrosis. The severity and duration of the regenerative effect is determined by the degree of joint damage. Based on international experience, it is possible to predict a persistent improvement within 3-5 years, and the possibility of postponing arthroplasty for an indefinite period.
Cell therapy for diseases and injuries of the musculoskeletal system is based on the use of biomedical cell products (BMCP). As a cellular component, we use autologous (i.e., our own) mesenchymal stem cells (MSC) isolated from the patient’s adipose tissue and cultured in laboratory conditions to the required amount. These stem cells, possessing a high differentiation and proliferative potential, are capable of chondrogenesis and are natural candidates for participation in the restoration of damaged joint cartilage tissue.
The department’s specialists have worked out the algorithm for this innovative treatment technology – from the initial examination of the patient and the collection of biomaterial (adipose tissue) to performing intra-articular cell transplantation under ultrasound guidance. The course of cell therapy for osteoarthritis of large joints (hip, knee, shoulder) includes several transplants with an interval of 10-14 days.
The clinical result of cell therapy for osteoarthritis is the relief of pain syndrome (usually within 2 to 3 weeks), improvement of the functional capabilities of the joint, and slowing of the progression of arthrosis. The severity and duration of the regenerative effect is determined by the degree of joint damage. Based on international experience, it is possible to predict a persistent improvement within 3-5 years, and the possibility of postponing arthroplasty for an indefinite period.
You can get the additional information and make an appointment with specialists at the following phone numbers:
+375 (17) 378 18 21
+375 (44) 574 18 21 (Viber, WhatsApp, Telegram)
e-mail: med@ibce.by